Dear customer, planned maintenance work will be carried out in our online store on January 11 from 10pm to midnight. For this reason, there may be functional restrictions during this period.
- Shop
- Transfection Reagents & Plasmids
- LipidBrick® Cell Ready
LipidBrick® Cell Ready 0,3 mL
Democratizing Gene-Modified Cell Therapy, Delivering Excellence: LipidBrick® Cell Ready is a Ready-to-Use Lipid-based Nanoparticle Solution Tailored for the Ex Vivo Transfection of Immune & Stem cells for Gene-Modified Cell Therapy applications.
- Item No.:
- 101000301
Democratizing Gene-Modified Cell Therapy, Delivering Excellence: LipidBrick® Cell Ready is a Ready-to-Use Lipid-based Nanoparticle Solution Tailored for the Ex Vivo Transfection of Immune & Stem cells for Gene-Modified Cell Therapy applications.
Overview
Specifications
Choose your Non-Viral Delivery Solutions
LipidBrick® Cell Ready is an advanced non-viral delivery system utilizing pre-formed lipid-based nanoparticles. It is meticulously optimized for the efficient delivery of nucleic acids delivery to a variety of human primary immune and stem cell types, such as T cells, NK cells and CD34+ hematopoietic stem cells. This versatile solution supports both transient protein expression, aiding in the development of mRNA CAR-T/NK cell therapies, and stable cell modifications through the delivery of genetic engineering tools such as CRISPR/transposons. In addition, it is designed to be gentle to cells, preserving cell growth and function, as well as offering scalability from well-plate screenings to bioreactor gene-modified cell therapy production.
Key Benefits:
- Cost-Efficiency: Ready-to-use reagent, with no specific equipment nor consumables required.
- High Performance: Excels in transient expression & stable modification using gene editing tools.
- High Cell Viability: Preserves cell viability, growth and function.
- Scalability: Suitable for well-plate screenings to bioreactor production.
- Flexibility: Accommodates diverse nucleic acid payloads across various immune & stem cells
Applications
-
ApplicationEx Vivo Gene-Modified Cell Therapy
-
Cell Type
-
Immune cells (e.g. T, NK, Dendritic, etc.)
- Stem cells (e.g. CD34+ HSCs)
-
Immune cells (e.g. T, NK, Dendritic, etc.)
Biological Information
-
Molecule delivered
-
mRNA, saRNA
-
gRNA
-
pDNA
-
nanoplasmid
- circRNA
-
mRNA, saRNA
-
Number of transfectionsDepending on the application, 0.3 mL is sufficient to transfect up to: ~1.8-5.6x108 human primary T cells ~1.8-2.8x108 human primary NK cells ~1.8-3.7x108 human CD34+ HSCs
Compliance Information
-
Product Documentation
-
Protocol
-
Certificate of Analysis
- Master Safety Data Sheet
-
Protocol
General Specifications
-
Amount of Reagent0.3 mL
-
Reagents and Kits TypeLipidBrick® Cell Ready
Product Information
-
Pack SizemRNA buffer 60 mL Bottle
-
Provided WithmRNA buffer
Storage Conditions
-
Storage Conditions
-
5 °C ± 3 °C
- Do not freeze
-
5 °C ± 3 °C
Volume
-
Volume0.3 mL